Artwork: Elena Lokshina, www.artblues.com John Mendelsohn had reached the pinnacle of his scientific career when he was called before US congressional investigators this autumn to answer questions ...

Last year, Yeda Research and Development, the tech transfer office of the Weizmann Institute, sued ImClone and Sanofi-Aventis over the Erbitux patent. (The patent was owned by the latter and licensed ...

The struggle to gain control over ImClone and its cancer medication Erbitux (cetuximab) has ended with Eli Lilly the victor. The Indianapolis-based company outbid its pharma rival Bristol-Myers ...